News und Analysen

Shares of UnitedHealth Group (NYSE: UNH) jumped more than 9% on Tuesday on news that Medicare Advantage rates would be going up by 2.48% in 2027. Previously, the Trump administration suggested just

AbbVie (NYSE: ABBV), spun off from Abbott Laboratories in 2013, has raised its quarterly dividend each year since becoming an independent, publicly traded company. This comes even as the North

On the second trading day of the week, Pfizer (NYSE: PFE) was a laggard on the stock exchange. An analyst reiterated his bearish view of the stock, and more than a few investors were obviously

Shares of UnitedHealth Group (NYSE: UNH) were rallying on Tuesday, up 10.5% as of 1:41 p.m. EDT.

UnitedHealth is the largest health insurer in America, and received a boost today after the

One of the most puzzling stocks these days is Pfizer (NYSE: PFE). Although it's not generating tons of money from its COVID vaccine and pill anymore, the business is still doing well. There are

UnitedHealth (NYSE: UNH) is a leader in the health insurance industry, but its share price hasn't been reflecting that of late. In just the past year, the stock has been nosediving, and it's now

AbbVie (NYSE: ABBV) is a leading drugmaker that investors have come to rely on for steady and consistent results over the years. Along the way, it has also paid and increased its dividend on a

Investors looking for stocks that can turn a modest portfolio into a multimillion-dollar nest egg often find what they're looking for in the biotech industry. For several years, CRISPR Therapeutics

Healthcare company Biogen (NASDAQ: BIIB) wasn't looking very healthy on the stock market on Monday. Investors traded out of its shares after learning that the company plans to book a hefty charge in

Shares of SoFi Technologies (NASDAQ: SOFI) fell 10.6% in March, according to data from S&P Global Market Intelligence. The digital banking platform faced some heat when a prominent short seller

UnitedHealth's (NYSE: UNH) stock has disappointed investors over the previous year.

*Stock prices used were the afternoon prices of April 2, 2026. The video was published on April 4, 2026.

Continue

Short-seller firm Muddy Waters recently asserted that SoFi Technologies (NASDAQ: SOFI) is engaging in financial shenanigans, to put it kindly, by inflating fair value gains in its portfolios.

SoFi

Many tech stocks have moved lower, along with the tech-heavy Nasdaq Composite, in recent months. This is partly because there are growing fears of a recession. While some beaten-down companies could

Stocks that perform well over the long run tend to have several traits, such as a large, growing market where they have a strong presence, solid financial results, and a competitive moat. Investing

Bullishness was in the air on the stock market on Tuesday, but you'd hardly know that from the performance of Biogen (NASDAQ: BIIB). The healthcare sector mainstay saw its share price slump by over

SoFi Technologies (NASDAQ: SOFI) has been a market laggard over the past six months. Given recent developments, things might not be about to get better. On March 17, Muddy Waters Research, a

Explore the exciting world of Regeneron Pharmaceuticals (NASDAQ: REGN) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable

Boston Scientific (NYSE:BSX), a maker of medical devices for interventional specialties, closed Monday at $62.92, down 9.03%. The stock moved lower on Monday as investors analyzed new clinical trial

Pfizer (NYSE: PFE) investors got some very bad news when the company was forced to abandon its internally developed GLP-1 weight loss drug in April, 2025. With patent expirations on the horizon

When you think of GLP-1s and investing, the two large pharmaceutical companies benefiting most from this trend may first come to mind. First, there's Novo Nordisk, the first to bring GLP-1 weight

One of the best ways to earn great returns in equity markets is to buy high-quality stocks and hold them for a long time. But it's not always simple to know which corporations have what it takes to

Regeneron (NASDAQ: REGN) has encountered several headwinds over the past two years, including the loss of patent exclusivity for one of its growth drivers, Eylea, a medicine for wet age-related

It's smart to seek dividend income from your investments because it can be used to help pay living expenses or to buy more stock. A solid dividend-paying stock to consider is pharmaceutical company